Mapping the Investor Landscape: Who Funds 'Unsexy' Tech?

Transcript

SPEAKER_1: Alright, so last time we landed on this idea that the brokerage sector's fragmentation is actually the pitch. Now the harder question: who actually writes the check for something like this? SPEAKER_2: That's where a lot of founders get stuck. They assume the same VCs funding the next consumer app will fund a brokerage platform. That's usually the wrong room entirely. SPEAKER_1: Why is it the wrong room? What makes generalist VCs a structural mismatch here? SPEAKER_2: Generalist funds are built around short life cycles and high-multiple exits. Business brokerage tech doesn't promise viral growth loops—it promises steady transaction volume and compounding workflow data. Those are different return shapes. And generalist investors often lack the in-house expertise to evaluate the regulatory nuance involved. SPEAKER_1: So if not generalist VCs, who should founders be targeting? What are the two main lanes? SPEAKER_2: The key idea is to think in two lanes. First, vertical SaaS venture funds—investors who back software built for a single industry. They understand a brokerage workflow tool doesn't need to be the next Salesforce to be enormously valuable. Second, industry-specific family offices. Think of a family that built wealth through M&A and now deploys capital into adjacent tech. They get the domain immediately. SPEAKER_1: Can someone listening get a concrete example of how that second lane actually plays out? SPEAKER_2: Think of agtech investing. Analyses of agtech deal data show that some of the most impactful on-farm technologies—farm management software, workflow sensors—attract modest valuations compared to flashy consumer food brands, but they pull in specialized funds and strategic agribusiness investors who care about real operational results. The same dynamic applies to brokerage tech. SPEAKER_1: So there's a whole category of investors actually drawn to steady, essential tech rather than repelled by it. SPEAKER_2: Exactly. And corporate venture capital is another important lane. Corporate VCs often focus on strategic fit and long-term capability building rather than purely short-term returns. A large brokerage network running a CVC arm might back a brokerage tech startup not just for return, but because the platform strengthens their own deal flow. SPEAKER_1: That's what people call strategic smart money versus silent capital. What's the real difference for a founder? SPEAKER_2: Strategic smart money comes with network access—introductions to brokerage firms, regulatory guidance, distribution partnerships. Silent capital is purely financial; it won't open doors. For a sector where trust and relationships are the currency, strategic smart money is often more valuable early. The check might be smaller, but the network effect compounds. SPEAKER_1: Now, what about the friction between traditional M&A culture and tech culture? That has to affect how investors perceive these startups. SPEAKER_2: It cuts both ways. Traditional M&A practitioners are skeptical of software-first founders who don't understand deal dynamics. Meanwhile, tech investors sometimes underestimate how relationship-driven and regulation-sensitive this sector is. The founders who navigate this best speak both languages fluently in the pitch room. SPEAKER_1: So how does a founder frame steady transaction volume as a feature rather than a limitation when pitching? SPEAKER_2: Infrastructure-like cash flows are a feature for the right investor. Low volatility, recurring revenue, long asset relationships—these are exactly what institutional investors with long-term liabilities find attractive. The same logic that makes essential infrastructure appealing to a pension fund can make a brokerage platform with steady transaction volume appealing to a patient capital fund. SPEAKER_1: Patient capital—what does that actually mean in practice for a brokerage tech startup? SPEAKER_2: Emerging frameworks for patient capital include evergreen venture structures and public-private fund vehicles designed specifically for sectors with longer development timelines. For a brokerage tech founder, targeting an evergreen fund means less pressure to exit in year five and more room to build the workflow data moat that makes the platform defensible over time. SPEAKER_1: And the takeaway for someone mapping their investor outreach right now? SPEAKER_2: Don't pitch the wrong room. Generalist VCs will often see the lack of viral growth and pass. The investors who will lean in are vertical SaaS funds, strategic corporate VCs with brokerage or M&A adjacency, and patient capital vehicles—including select family offices—who value steady transaction volume and compounding operational data over headline growth metrics. Find the investors who already understand that essential, unglamorous infrastructure is where durable value lives.